Sequence assignments in partially replicate design [Design Issues]

posted by Loky do – Egypt, 2020-07-19 03:33 (1371 d 01:20 ago) – Posting: # 21746
Views: 2,441

Dears

In partially replicate 3-way design, FDA recommends using the following example for sequence assignments 1,2,3 --> (TRR, RTR, RRT), if we used different sequence assignments 1,2,3 --> (TRR, RRT, RTR), is this change significant? or is it ok as long as it's considered in statistical analysis?

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,653 registered users;
89 visitors (0 registered, 89 guests [including 7 identified bots]).
Forum time: 04:54 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5